In this episode we have a riveting discussion with Dr. Jon Friedman the Chief Medical Officer of Transplant Genomics. Dr. Friedman, joined Transplant Genomics as Chief Medical Officer in February 2022 after 22 years with Optum/United Health Group. Dr. Friedman is a Fellow of the American Society of Transplantation and received an AST Distinguished Service Award for his efforts in breaking down financial barriers in support of living kidney donors. Tune in for discussion on the use of blood tests to avoid biopsies, how we are working towards decreasing the amount of immmunosupresion meds in the future, and the future direction of transplant medicine!
Email: bothsidesofthestethoscope@gmail.com
Instagram: @bothsidesofthestethoscope
Twitter: @bsotsthethoscope
In this episode we have a riveting discussion with Dr. Jon Friedman the Chief Medical Officer of Transplant Genomics. Dr. Friedman, joined Transplant Genomics as Chief Medical Officer in February 2022 after 22 years with Optum/United Health Group. Dr. Friedman is a Fellow of the American Society of Transplantation and received an AST Distinguished Service Award for his efforts in breaking down financial barriers in support of living kidney donors. Tune in for discussion on the use of blood tests to avoid biopsies, how we are working towards decreasing the amount of immmunosupresion meds in the future, and the future direction of transplant medicine!
Email: bothsidesofthestethoscope@gmail.com
Instagram: @bothsidesofthestethoscope
Twitter: @bsotsthethoscope